Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
55.54
Dollar change
-0.11
Percentage change
-0.20
%
IndexS&P 500 P/E9.76 EPS (ttm)5.69 Insider Own0.18% Shs Outstand1.29B Perf Week-3.71%
Market Cap69.72B Forward P/E7.01 EPS next Y7.93 Insider Trans-0.85% Shs Float1.25B Perf Month-17.51%
Income7.32B PEG- EPS next Q1.79 Inst Own81.64% Short Float0.91% Perf Quarter-27.33%
Sales361.35B P/S0.19 EPS this Y-18.74% Inst Trans0.60% Short Ratio0.99 Perf Half Y-19.67%
Book/sh59.08 P/B0.94 EPS next Y11.62% ROA2.99% Short Interest11.37M Perf Year-19.30%
Cash/sh10.47 P/C5.31 EPS next 5Y-0.30% ROE10.07% 52W Range53.70 - 83.25 Perf YTD-29.66%
Dividend Est.2.59 (4.66%) P/FCF8.57 EPS past 5Y- ROI4.97% 52W High-33.29% Beta0.51
Dividend TTM2.54 (4.57%) Quick Ratio0.61 Sales past 5Y13.36% Gross Margin14.95% 52W Low3.43% ATR (14)1.67
Dividend Ex-DateApr 19, 2024 Current Ratio0.81 EPS Y/Y TTM85.89% Oper. Margin3.90% RSI (14)26.74 Volatility2.64% 2.52%
Employees300000 Debt/Eq1.11 Sales Y/Y TTM9.11% Profit Margin2.03% Recom1.93 Target Price68.24
Option/ShortYes / Yes LT Debt/Eq0.99 EPS Q/Q-46.91% Payout38.34% Rel Volume1.02 Prev Close55.65
Sales Surprise-1.00% EPS Surprise-22.73% Sales Q/Q3.60% EarningsMay 01 BMO Avg Volume11.46M Price55.54
SMA20-4.21% SMA50-17.72% SMA200-21.90% Trades Volume11,712,617 Change-0.20%
Date Action Analyst Rating Change Price Target Change
May-07-24Downgrade TD Cowen Buy → Hold $99 → $59
May-02-24Downgrade UBS Buy → Neutral $85 → $60
May-01-24Downgrade Leerink Partners Outperform → Market Perform $87 → $60
May-01-24Downgrade Cantor Fitzgerald Overweight → Neutral
Mar-06-24Initiated Barclays Equal Weight $78
Feb-26-24Initiated Leerink Partners Outperform $88
Dec-22-23Initiated HSBC Securities Buy $94
Sep-19-23Upgrade Evercore ISI In-line → Outperform $81 → $83
Sep-12-23Upgrade Wolfe Research Peer Perform → Outperform $80
Aug-18-23Downgrade Edward Jones Buy → Hold
May-26-24 05:51AM
May-24-24 04:14PM
03:49PM
09:30AM
May-23-24 03:38PM
08:05AM Loading…
08:05AM
May-22-24 05:22PM
05:17PM
01:12PM
May-21-24 05:30AM
May-20-24 07:24PM
02:41PM
09:00AM
09:00AM
May-19-24 01:15PM
09:58AM Loading…
May-17-24 09:58AM
08:10AM
07:17AM
07:11AM
07:00AM
May-16-24 03:29PM
11:13AM
08:27AM
07:00AM
May-15-24 04:57AM
04:16AM
May-14-24 01:23PM
06:08AM
May-13-24 09:00PM
04:03PM
04:03PM Loading…
04:03PM
May-11-24 09:15AM
May-10-24 11:15PM
03:24PM
03:16PM
May-09-24 10:37AM
09:00AM
09:00AM
May-08-24 03:41PM
01:36PM
11:22AM
09:30AM
08:00AM
07:52AM
06:30AM
May-07-24 04:43PM
04:00PM
03:55PM
01:31PM
12:46PM
11:03AM
06:35AM
05:44AM
May-06-24 10:16AM
06:00AM
05:15AM
May-04-24 10:48AM
05:17AM
May-03-24 07:42PM
03:05PM
02:22PM
12:57PM
12:37PM
11:41AM
08:51AM
05:28AM
May-02-24 07:37PM
10:56AM
10:18AM
10:17AM
10:10AM
10:07AM
09:50AM
09:47AM
09:41AM
09:21AM
08:38AM
07:11AM
07:03AM
06:48AM
06:41AM
06:39AM
06:34AM
03:02AM
01:05AM
May-01-24 11:09PM
05:40PM
05:06PM
04:54PM
04:00PM
03:10PM
03:02PM
02:38PM
02:37PM
02:34PM
01:46PM
01:46PM
01:25PM
01:15PM
12:31PM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mahoney Michael FDirectorMay 02 '24Buy54.499,181500,2949,356May 02 04:30 PM
LUDWIG EDWARD JDirectorMay 02 '24Buy53.881,00053,87921,630May 02 04:31 PM
Shah Prem SEVP and Pres-Pharm, Consumer WFeb 16 '24Sale76.9529,4732,267,94739,765Feb 16 06:46 PM
LUDWIG EDWARD JDirectorNov 03 '23Buy70.472,000140,93020,630Nov 06 10:59 AM
Clark James DavidSVP, Cont & Chief Acct OfficerAug 03 '23Sale74.9225,7591,930,0044,698Aug 04 05:41 PM